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PUBLIC HEALTH COUNCIL 
MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH 
Henry I. Bowditch Public Health Council Room, 2nd Floor 
250 Washington Street, Boston MA 
 
  
 
Docket:  Wednesday, October 25, 2019 - 9:00 AM 
  
 
1. EXECUTIVE SESSION 
a. After a call to order, the Public Health Council will meet in Executive Session as 
authorized by M.G.L. c. 30A, s. 21(a)(3) for the purpose of discussing strategy with 
respect to litigation, specifically: 
a. Vapor Technology Association v. Charlie Baker, in official capacity and 
Monica Bharel, in official capacity   
b. Mass Dynamics et. al. v. Charles Baker, as Governor and Monica Bharel, as 
Commissioner of Public Health   
c. Vapor Zone v. DPH et al.  
d. Vapor Technology Association v. Charlie Baker, in official capacity and 
Monica Bharel, in official capacity   
2. EMERGENCY	REGULATION	
a. Request	to	Approve	Proposed	Emergency	Regulation	105	CMR	800.000,	Severe	Lung		
	 Disease	Associated	with	Vaping	Products	(Vote)	
b. Additional	related	regulations	as	may	be	necessary	(Vote)	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Commissioner and the Public Health Council are defined by law as constituting the Department of 
Public Health. The Council has one regular meeting per month. These meetings are open to public 
attendance except when the Council meets in Executive Session. The Council’s meetings are not hearings, 
nor do members of the public have a right to speak or address the Council. The docket will indicate 
whether or not floor discussions are anticipated. For purposes of fairness since the regular meeting is not 
a hearing and is not advertised as such, presentations from the floor may require delaying a decision 
until a subsequent meeting.  
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Public Health Council 
Attendance and Summary of Votes: 
Presented below is a summary of the meeting, including time-keeping, attendance and votes cast.  
Date of Meeting: Wednesday, October 25, 2019 
Start Time: 9:21am Ending Time:  10:02am 
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Board Member Attended Vote:  105 CMR 800.000 
Monica Bharel Yes Yes 
Edward Bernstein  Yes  Yes 
Lissette Blondet Absent  
Derek Brindisi Yes Yes 
Kathleen Carey Yes Yes 
Harold Cox Absent Absent 
John Cunningham Yes Yes 
Michele David Yes Yes 
Michael Kneeland Yes Yes 
Keith Hovan Yes Yes 
Joanna Lambert Absent Absent 
Secretary Elizabeth Chen Absent Absent 
Lucilia Prates-Ramos Yes Yes 
Secretary Francisco Ureña Yes Yes 
Summary 10 members present, 4 members absent 
10 members approve, 4 
members absent 
		
PROCEEDINGS: 
An emergency meeting of the Massachusetts Department of Public Health’s Public Health Council 
(M.G.L. c. 17, §§ 1, 3) was held on Friday October 25, 2019 at the Massachusetts Department of Public 
Health, 250 Washington Street, Henry I. Bowditch Public Health Council Room, 2nd Floor, Boston, 
Massachusetts 02108. 
 
Members present were: Monica Bharel, MD, MPH; Edward Bernstein; Derek Brindisi; John 
Cunningham, PhD; Michael Kneeland, MD; Keith Hovan; Lucilia Prates-Ramos; Michele David;	
Secretary Francisco Ureña and	Kathleen Carey PhD 
 
Absent member(s) were:  Joanna Lambert, Lissette Blondet,	Harold Cox and Secretary Elizabeth Chen 
  
Also in attendance was Margret Cooke, General Counsel at the Massachusetts Department of Public 
Health. 
 
Commissioner Bharel called the emergency meeting to order at 9:21 AM and before moving into the 
public portion of our meeting,  Commissioner Bharel requested the Public Health Council meet in 
Executive Session as authorized by M.G.L. c. 30A, s. 21(a)(3) for the purpose of discussing strategy with 
respect to litigation, specifically: 
• Vapor Technology Association v. Charlie Baker, in official capacity and Monica Bharel, in 
official capacity   
• Mass Dynamics et. al. v. Charles Baker, as Governor and Monica Bharel, as Commissioner of 
Public Health   
• Vapor Zone v. DPH et al.  
• Vapor Technology Association v. Charlie Baker, in official capacity and Monica Bharel, in 
official capacity   
 
Ms. Prates Ramos made a motion to enter Executive Session, Dr. Bernstein seconded it.  
 
Following the motion, a roll call of all members was conducted, and the Council moved into Executive 
Session at 9:22am. 
 
Prior to moving into executive session, Commissioner Bharel asked all clear the room except for the 
Council and Department staff required to attend the executive session.   
At the conclusion of the executive session, Department staff notified members of the public and other 
DPH staff they may re-enter the Council room. 
 
The public portion of the Public Health Council meeting resumed at 9:39am.  
 
Commissioner Bharel stated that on September 24, 2019 the Baker Administration declared a public 
health emergency and imposed a temporary ban on all vape products to allow us time to better understand 
what is making people sick and leading to deaths in some cases  
The Centers for Disease Control and Prevention has issued clear warnings stating that the outbreak of 
these vaping-related illnesses and deaths cannot at this time be attributed to a single substance or product. 
Yesterday the CDC reported 1604 cases have been reported to them and 34 deaths. When we came 
together on September 24 to address this public health emergency, the Public Health Council approved 
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the order to prohibit the sale of all vaping products in retail establishments, online, and through any other 
means, including all non-flavored and flavored vaping products, including mint and menthol, including 
tetrahydrocnnabinol (THC) and any other cannabinoid, in the Commonwealth. Further, an additional 
order expanded access to nicotine replacement therapy through a statewide standing order.  
In continued response to the emergency that vaping-related lung disease presents for the Commonwealth, 
the Department now proposes an emergency regulation to ensure the continued and necessary 
prohibitions on sales of vaping products in Massachusetts in order to protect the public health.  
Commissioner Bharel stated the basis for the actions of September 24th, as follows:   
• As described in the DPH September 24, 2019 memo to the Council, clinicians here in 
Massachusetts and across the country began raising concerns in August 2019 related to possible 
cases of unexplained vaping-associated pulmonary illness.    
• On August 30, 2019, the Centers for Disease Control and Prevention (CDC) released a clinical 
advisory providing background information on e-cigarette products, information on the multistate 
outbreak of severe pulmonary disease associated with e-cigarettes, and clinical features of 
patients with severe pulmonary disease, with a recommendation clinicians report all cases of 
severe pulmonary disease of unclear etiology and a history of e-cigarette product use within the 
past 90 days to state or local health departments.  
• In response to trends nationwide, CDC recommendations, and growing public health concerns in 
Massachusetts, I declared on September 11 that all suspected cases of unexplained e-cigarette or 
vaping-associated pulmonary disease be immediately reportable to our Department of Public 
Health for the next 12 months.  Since that declaration, the Department has received 184 reports 
from clinicians of suspected vaping-related disease in Massachusetts residents. Of these reports, 
the Department has reported to the CDC 16 cases which meet the CDC definition for confirmed 
case, and 30 cases which meet the CDC definition for probable case; the remainder still remains 
under Department investigation.   
• These reports of vaping-related illness represent a threefold increase in reports received and five 
times the number of confirmed cases reported to Council members a month ago.  Additionally, 
during that same timeframe, the Department also reported one fatality as a result of vaping-
related disease.  
• While cases still show a history of vaping and a history of using vaping products containing 
tetrahydrocannabinol (THC), nicotine, or a combination of both, the cause of the disease 
continues to remain unknown.  To date, no specific vaping product, including the related devices 
and liquids, or other substance has been identified as linked to all cases.  
• Due to the continued, significant danger vaping products present during the ongoing investigation 
into the cause of vaping-related disease, the CDC issued guidance last week advising that since 
the specific compound or ingredient causing lung injury is not yet known, the only way to assure 
that you are not at risk while the investigation continues is to consider refraining from use of all 
e-cigarette, or vaping, products.  
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• In addition to the public health concerns which Commissioner Bharel had outlined, in response to 
pending litigation related to the ban on sales of vaping products.  
Commissioner Bharel then proposed the Council vote to approve emergency regulations to maintain the 
ban during what will be an ongoing regulatory process.  These regulations will serve to preserve the 
existing ban on sales of vaping products in order to protect public health, continue our investigation into 
instances of this disease in Massachusetts residents, and learn from the CDC’s nationwide investigation. 
The proposed emergency regulation adopts all Orders issued pursuant to the Governor’s Declaration.   
Mr. Brindisi asked if this regulation will stay in place beyond the ban. 
Ms. Cooke stated there will be a public comment period and will be filed today if we pass the regulation.  
There may be some changes to the regulations in response to public input and then will come back to the 
PHC for approval. Emergency Regulations stay in place for 90 days if we do not file promulgation.  
Mr. Brindisi asked if the nicotine replacement therapy could be explained further.  
Commissioner Bharel stated that we emphasized nicotine cessation accessibility would be put in place to 
decrease cost barriers for access for FDA approved nicotine replacement treatments over the counter to 
decrease insurance barriers.   
Secretary Urena asked if there is data on the usage of nicotine replacement therapy.  
Commissioner Bharel stated DPH will be evaluating the data regarding NRT, but it can be difficult since 
many therapies are over the counter but is part of our plan.  
Dr. Cunningham asked if the CDC data shows nicotine only lung disease confirmed cases. 
Commissioner Bharel stated it fluctuates but usually around 10% and the CDC advisory stated to avoid 
any of the products if people want to be safe since the cause is not known, but there is an association in 
many of the cases with nicotine only but the cause is unknown at this time at the CDC level. 
Dr. Cunningham asked if we pass emergency regulation today that would go into effect the afternoon, 
does the Monday deadline still remain in effect. 
Ms. Cooke stated the ban would be kept in place for THC products absent flower product for vaping and 
the judge would have to separate out nicotine and THC. 
Dr. Cunningham with a new regulation in place, would there be a specific separation of which part will be 
banned.  
Dr. Kneeland stated that 10% is not a small number and is significant. 
Dr. Bernstein asked if there will be a preamble or just the regulation alone. 
Ms. Cooke stated that it would be the regulation standing alone.  
Dr. Bernstein asked if we can look into taxes on cigarettes to see if there is an increase in use and the 
black market on these products.  
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Dr. Cunningham asked if DPH is tracking the frequency of vaping in terms of dose response. 
Commissioner Bharel stated the definition is if used in the past 90 days, but will need to look into the 
frequency of use.  
Dr. Bernstein asked if the flower is included 
Ms. Cooke stated yes the flower is included and all THC products 
Commissioner Bharel stated that this regulation covers everything that the ban covered. 
Dr. Bernstein asked if the PHC is voting on the entire regulation. 
Commissioner Bharel stated yes.  
Commissioner Bharel stated that we still want to allow for prescriptions for medical marijuana. 
Dr. Bernstein stated that we would want to allow all FDA approved products and should include over the 
counter medications and treatments. 
Commissioner Bharel stated that the standing order would be to decrease the insurance barrier and not 
changing prescription criteria.   
Commissioner Bharel asked if there is motion to change 800.035from nicotine replacement therapy to 
over the counter nicotine replacement therapy. 
Dr. Bernstein made the motion; Secretary Urena seconded it, all other present members approved.  
Commissioner Bharel requested that the Council vote to approve the proposed regulation, 105 CMR 
800.000, on an emergency basis, which would take effect immediately upon filing with the Secretary of 
State’s office.   
Mr. Brindisi made a motion to approve the regulation; Dr. David seconded it, all other present members 
approved.  
Commissioner Bharel stated that this concludes our final agenda item for the day.  A friendly reminder, 
our next meeting is scheduled for Wednesday, November 20, 2019, at 9AM. 
 
She then asked for a motion to adjourn.  Dr. David made the motion, Dr. Carey seconded it. All present 
members approved. 
 
The meeting adjourned at 10:02AM.  
 
	
